Filtered By:
Vaccination: Meningitis Vaccine
This page shows you your search results in order of date. This is page number 19.
Order by Relevance | Date
Total 2891 results found since Jan 2013.
Low Vaccine Coverage and Factors Associated with Incomplete Childhood Immunization in Racial/Ethnic Minorities and Rural Groups, Central Brazil
Vaccines (Basel). 2023 Apr 13;11(4):838. doi: 10.3390/vaccines11040838.ABSTRACTDiscrimination and limited access to healthcare services in remote areas can affect vaccination coverage. Therefore, this study aimed to estimate vaccination coverage for children living in quilombola communities and rural settlements in the central region of Brazil during their first year of life and to analyze the factors associated with incomplete vaccination. An analytical cross-sectional study was conducted on children born between 2015 and 2017. The percentage of children who received all vaccines recommended by the National Immunization P...
Source: Rural Remote Health - April 28, 2023 Category: Rural Health Authors: Juliana de Oliveira Roque E Lima Val éria Pagotto B árbara Souza Rocha Paulo S érgio Scalize Rafael Alves Guimar ães M árcio Dias de Lima Leandro Nascimento da Silva Michele Dias da Silva Oliveira Winny Éveny Alves Moura Sheila Ara újo Teles Claci Source Type: research
Influenza, Pneumococcal and Herpes Zoster Vaccination Rates in Patients with Autoimmune Inflammatory Rheumatic Diseases
CONCLUSIONS: The frequencies of vaccinations against influenza, Streptococcus pneumoniae and HZ have increased during recent years. While this can be partly explained by continuous efforts in patient education during the outpatient visits, the COVID-19 pandemic might also have contributed. Nevertheless, the persistently high incidence and mortality of these preventable diseases in patients with AIIRDs mandates further efforts to increase vaccination coverage, particularly in SLE patients.PMID:37112672 | PMC:PMC10146832 | DOI:10.3390/vaccines11040760
Source: Herpes - April 28, 2023 Category: Infectious Diseases Authors: Marco Krasselt Ulf Wagner Olga Seifert Source Type: research
Low Vaccine Coverage and Factors Associated with Incomplete Childhood Immunization in Racial/Ethnic Minorities and Rural Groups, Central Brazil
Vaccines (Basel). 2023 Apr 13;11(4):838. doi: 10.3390/vaccines11040838.ABSTRACTDiscrimination and limited access to healthcare services in remote areas can affect vaccination coverage. Therefore, this study aimed to estimate vaccination coverage for children living in quilombola communities and rural settlements in the central region of Brazil during their first year of life and to analyze the factors associated with incomplete vaccination. An analytical cross-sectional study was conducted on children born between 2015 and 2017. The percentage of children who received all vaccines recommended by the National Immunization P...
Source: Rural Remote Health - April 28, 2023 Category: Rural Health Authors: Juliana de Oliveira Roque E Lima Val éria Pagotto B árbara Souza Rocha Paulo S érgio Scalize Rafael Alves Guimar ães M árcio Dias de Lima Leandro Nascimento da Silva Michele Dias da Silva Oliveira Winny Éveny Alves Moura Sheila Ara újo Teles Claci Source Type: research
Influenza, Pneumococcal and Herpes Zoster Vaccination Rates in Patients with Autoimmune Inflammatory Rheumatic Diseases
CONCLUSIONS: The frequencies of vaccinations against influenza, Streptococcus pneumoniae and HZ have increased during recent years. While this can be partly explained by continuous efforts in patient education during the outpatient visits, the COVID-19 pandemic might also have contributed. Nevertheless, the persistently high incidence and mortality of these preventable diseases in patients with AIIRDs mandates further efforts to increase vaccination coverage, particularly in SLE patients.PMID:37112672 | DOI:10.3390/vaccines11040760
Source: Herpes - April 28, 2023 Category: Infectious Diseases Authors: Marco Krasselt Ulf Wagner Olga Seifert Source Type: research
A Phase III, multicenter, randomized, double-blind, active comparator-controlled study to evaluate the safety, tolerability, and immunogenicity of V114 compared with PCV13 in healthy infants (PNEU-PED-EU-1)
CONCLUSIONS: After a 2+1 schedule, V114 elicited non-inferior immune responses to 13 shared serotypes and superior responses to the two additional serotypes compared with PCV13, with comparable safety profile. These results support the routine use of V114 in infants.TRIAL REGISTRATION: ClinicalTrials.gov: NCT04031846; EudraCT: 2018-003787-31.PMID:37105892 | DOI:10.1016/j.vaccine.2023.04.036
Source: Vaccine - April 27, 2023 Category: Allergy & Immunology Authors: Federico Martinon-Torres Jacek Wysocki Leszek Szenborn Alfonso Carmona-Martinez Airi Poder Ron Dagan Peter Richmond Christopher Gilbert Marie-Chantale Trudel Sheryl Flores Robert Lupinacci Richard McFetridge Richard T Wiedmann Qiuxu Chen Han Gerrits Natal Source Type: research
Improved plasmablast response after repeated pneumococcal revaccinations following primary immunization with 13-valent pneumococcal conjugate vaccine or 23-valent pneumococcal polysaccharide vaccine in patients with chronic lymphocytic leukemia
CONCLUSION: In CLL patients, pneumococcal revaccination induced minor early plasmablast response compared to controls, but the response improved using a strategy of repeated doses with of conjugated T cell dependent pneumococcal vaccine.PMID:37061372 | DOI:10.1016/j.vaccine.2023.04.016
Source: Vaccine - April 15, 2023 Category: Allergy & Immunology Authors: Magdalena K ättström Bertil Uggla Elisabet Tina Eva Kimby Torbj örn Norén Simon Athlin Source Type: research
Prevalence, capsular types, antimicrobial resistance and risk factors associated with pneumococcal carriage among children after long-term 10-valent pneumococcal conjugate vaccine use in Brazil
CONCLUSIONS: Long-term universal childhood use of PCV10 has nearly eliminated carriage with PCV10 serotypes, but the high frequency of MDR isolates, especially associated with serotype 6C/D, remains a concern. Replacing PCV10 with PCV13 should reduce the proportion of ERY-R isolates and PNSP by at least 14% and 18%, respectively.PMID:37061371 | DOI:10.1016/j.vaccine.2023.04.023
Source: Vaccine - April 15, 2023 Category: Allergy & Immunology Authors: Let ícia B D P Fortuna Filipe M Miranda Isa M F Antunes Amanda B Silva Amanda S Cabral Ítalo M Dolores Nayara T Cardoso-Marques L úcia M Teixeira Felipe P G Neves Source Type: research
Improved plasmablast response after repeated pneumococcal revaccinations following primary immunization with 13-valent pneumococcal conjugate vaccine or 23-valent pneumococcal polysaccharide vaccine in patients with chronic lymphocytic leukemia
CONCLUSION: In CLL patients, pneumococcal revaccination induced minor early plasmablast response compared to controls, but the response improved using a strategy of repeated doses with of conjugated T cell dependent pneumococcal vaccine.PMID:37061372 | DOI:10.1016/j.vaccine.2023.04.016
Source: Vaccine - April 15, 2023 Category: Allergy & Immunology Authors: Magdalena K ättström Bertil Uggla Elisabet Tina Eva Kimby Torbj örn Norén Simon Athlin Source Type: research
Prevalence, capsular types, antimicrobial resistance and risk factors associated with pneumococcal carriage among children after long-term 10-valent pneumococcal conjugate vaccine use in Brazil
CONCLUSIONS: Long-term universal childhood use of PCV10 has nearly eliminated carriage with PCV10 serotypes, but the high frequency of MDR isolates, especially associated with serotype 6C/D, remains a concern. Replacing PCV10 with PCV13 should reduce the proportion of ERY-R isolates and PNSP by at least 14% and 18%, respectively.PMID:37061371 | DOI:10.1016/j.vaccine.2023.04.023
Source: Vaccine - April 15, 2023 Category: Allergy & Immunology Authors: Let ícia B D P Fortuna Filipe M Miranda Isa M F Antunes Amanda B Silva Amanda S Cabral Ítalo M Dolores Nayara T Cardoso-Marques L úcia M Teixeira Felipe P G Neves Source Type: research
Improved plasmablast response after repeated pneumococcal revaccinations following primary immunization with 13-valent pneumococcal conjugate vaccine or 23-valent pneumococcal polysaccharide vaccine in patients with chronic lymphocytic leukemia
CONCLUSION: In CLL patients, pneumococcal revaccination induced minor early plasmablast response compared to controls, but the response improved using a strategy of repeated doses with of conjugated T cell dependent pneumococcal vaccine.PMID:37061372 | DOI:10.1016/j.vaccine.2023.04.016
Source: Vaccine - April 15, 2023 Category: Allergy & Immunology Authors: Magdalena K ättström Bertil Uggla Elisabet Tina Eva Kimby Torbj örn Norén Simon Athlin Source Type: research
Prevalence, capsular types, antimicrobial resistance and risk factors associated with pneumococcal carriage among children after long-term 10-valent pneumococcal conjugate vaccine use in Brazil
CONCLUSIONS: Long-term universal childhood use of PCV10 has nearly eliminated carriage with PCV10 serotypes, but the high frequency of MDR isolates, especially associated with serotype 6C/D, remains a concern. Replacing PCV10 with PCV13 should reduce the proportion of ERY-R isolates and PNSP by at least 14% and 18%, respectively.PMID:37061371 | DOI:10.1016/j.vaccine.2023.04.023
Source: Vaccine - April 15, 2023 Category: Allergy & Immunology Authors: Let ícia B D P Fortuna Filipe M Miranda Isa M F Antunes Amanda B Silva Amanda S Cabral Ítalo M Dolores Nayara T Cardoso-Marques L úcia M Teixeira Felipe P G Neves Source Type: research
Secondary Cases of Invasive Disease Caused by Encapsulated and Nontypeable Haemophilus influenzae - 10 U.S. Jurisdictions, 2011-2018
MMWR Morb Mortal Wkly Rep. 2023 Apr 14;72(15):386-390. doi: 10.15585/mmwr.mm7215a2.ABSTRACTHaemophilus influenzae (Hi) can cause meningitis and other serious invasive disease. Encapsulated Hi is classified into six serotypes (a-f) based on chemical composition of the polysaccharide capsule; unencapsulated strains are termed nontypeable Hi (NTHi). Hi serotype b (Hib) was the most common cause of bacterial meningitis in children in the pre-Hib vaccine era, and secondary transmission of Hi among children (e.g., to household contacts and in child care facilities) (1,2) led to the Advisory Committee on Immunization Practices (A...
Source: MMWR Morb Mortal Wkl... - April 13, 2023 Category: Epidemiology Authors: Sara E Oliver Amy B Rubis Heidi M Soeters Arthur Reingold Meghan Barnes Susan Petit Ashley E Moore Lee H Harrison Ruth Lynfield Kathy M Angeles Kari E Burzlaff Ann Thomas William Schaffner Henju Marjuki Xin Wang Susan Hariri Source Type: research
